Lexicon publishes White Paper on treatments for chronic pain

Lexicon (LXRX) Pharmaceuticals convened an in-person Roundtable in Washington, D.C., to “better understand the unmet needs of people living with chronic pain and identify what more can be done to benefit patients and society at large,” the company said. The White Paper summarizing the findings, titled “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain.” “We are exploring with partners how to add chronic pain to the legislative agenda, and how to help policymakers and payers prioritize new methods of pain relief,” said Mike Exton, Ph.D., Lexicon’s chief executive officer and director. “We believe that non-opioid treatments are going to be incredibly important, not only for the patient, but for society at large.”